GHRH analogue combined with selective GH secretagogue in one vial.
CJC-1295 is a GHRH analogue with extended half-life, combined with Ipamorelin, a selective pentapeptide GH secretagogue. Supplied as a co-lyophilized research blend for GH axis pathway studies. Both compounds independently HPLC-verified. ≥99% purity.
⚠ FOR RESEARCH USE ONLY, CJC-1295 / Ipamorelin is supplied exclusively for in vitro and laboratory research applications. Not approved by the FDA for human consumption or therapeutic use. Not a drug, supplement, or medical treatment. Purchasers are responsible for compliance with all applicable regulations.